New product newswire: March 5, 2007

Ruxolitinib (Opzelura) cream is the first and only FDA-approved treatment for patients with vitiligo.

Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

Merck and Ridgeback Biotherapeutics have announced their submission of an EUA application to the FDA for an oral antiviral medication for the treatment of COVID-19.

Five medications are currently approved by the FDA for chronic weight management.

Sol-Gel Technologies has created a single-application acne treatment cream, combining 2 commonly used ingredients: tretinoin and benzoyl peroxide.

The FDA has approved the AstraZeneca once-weekly injectable therapy for use in children aged 10 to 17 years.